5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats

Psychopharmacology
Paula D HatcherD N C Jones

Abstract

Performance on the Wisconsin Card Sorting Test (WCST), which requires patients to 'shift attention' between stimulus dimensions (sorting categories), is impaired in diseases such as schizophrenia. The rat attentional set shifting task is an analogue of the WCST. Given that 5-HT(6) receptor antagonists improve cognitive performance and influence cortical neurochemistry in rats, the present study investigated the effects of 5-HT(6) receptor antagonists upon attentional set shifting in rats. Rats were tested in this paradigm following sub-chronic SB-399885-T or SB-271046-A (both 10 mg kg(-1) bid, p.o. for 8 days prior to testing and either 4 or 2 h prior to testing on day 9, respectively). Rats were trained to dig in baited bowls for a food reward and to discriminate based on odour or digging media (Habituation, day 8). In a single session (day 9), rats performed a series of discriminations, including reversals (REV), intra-dimensional (ID) and extra-dimensional (ED) shifts. Neither compound altered performance during Habituation. On the test day, both SB-399885-T and SB-271046-A reduced the total trials to reach criterion and the total errors made when data were collapsed across all discriminations (P<0.05-0.01). Further, both co...Continue Reading

References

Oct 18, 2008·Psychopharmacology·David S TaitVerity J Brown
May 23, 2009·Psychopharmacology·Hugh M MarstonMohammed Shahid
Nov 11, 2009·Psychopharmacology·Katherine E BurnhamTrevor Sharp
Mar 11, 2010·Psychopharmacology·Gregory V CarrIrwin Lucki
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Neil UptonDavid J Virley
Nov 27, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Naomi A FinebergEric Hollander
Sep 17, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stan B Floresco, James D Jentsch
Jun 23, 2012·Nature Reviews. Drug Discovery·Judith PrattBrian Morris
Jul 14, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stan B FlorescoMaric T L Tse
Feb 3, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stephen J BonaseraLaurence H Tecott
Dec 29, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ellen S MitchellJohn F Neumaier
Dec 21, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Joshua S RodeferJørn Arnt
Jan 23, 2013·Journal of Chemical Neuroanatomy·Stephanie B LinleyRobert P Vertes
Mar 23, 2011·Pharmacology, Biochemistry, and Behavior·Segev Barak, Ina Weiner
Feb 15, 2011·Pharmacology, Biochemistry, and Behavior·Alvin V TerryScott J Webster
Dec 28, 2010·Neuropharmacology·V ValentiniG Di Chiara
Jan 29, 2010·Neuroscience and Biobehavioral Reviews·Jennifer H BarnettAndrew D Blackwell
Sep 8, 2009·Neurobiology of Learning and Memory·A Huerta-RivasA Meneses
Jul 19, 2015·Behavioural Brain Research·Anne QuiedevilleValentine Bouet
Aug 22, 2007·Neurobiology of Learning and Memory·Martha F McCoolMichael E Ragozzino
Sep 22, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·R E FeatherstoneP J Fletcher
Aug 5, 2008·Journal of Neuroendocrinology·M D S Lapiz-BluhmD A Morilak
Apr 14, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kevin P SnyderRita J Valentino
Jul 11, 2012·Neuropharmacology·Claire Allison, Mohammed Shoaib

Citations

May 28, 1993·Biochemical and Biophysical Research Communications·M RuatJ C Schwartz
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M RuatJ C Schwartz
Jan 12, 1999·British Journal of Pharmacology·A BoursonA J Sleight
Jul 31, 1999·Schizophrenia Research·J A Frederick, J H Meador-Woodruff
Aug 5, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M HamonD Vergé
Aug 26, 1999·Neuropharmacology·N M Barnes, Trevor Sharp
Jul 13, 2000·Neuroscience Letters·N L Zhukovskaya, John F Neumaier
Aug 6, 2000·British Journal of Pharmacology·C RoutledgeD N Middlemiss
Aug 8, 2001·Neuropharmacology·Marie L WoolleyK C F Fone
Nov 10, 2001·Psychopharmacology·Derek C Rogers, Jim J Hagan
Jul 26, 2003·Progress in Neurobiology·Thérèse M Jay
Sep 17, 2003·The Journal of Pharmacology and Experimental Therapeutics·Mark D LindnerValentin K Gribkoff
Sep 27, 2003·Progress in Neurobiology·Denis Paré
Oct 23, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andrew G FoleyCiaran M Regan
Dec 4, 2003·Behavioural Brain Research·Kerry McAlonan, Verity J Brown
Feb 18, 2004·Current Drug Targets. CNS and Neurological Disorders·Marie L WoolleyK C F Fone
Apr 3, 2004·Nature Reviews. Drug Discovery·Bryan L RothWesley K Kroeze
Jul 1, 1948·The Journal of General Psychology·E A BERG

Related Concepts

Serotonin 6 receptor
Thiophenes
OR2H1
Schizophrenia
Piperazines
Analog
REV1
Receptors, Tryptamine
Extra-Adrenal Paraganglioma
SB 271046

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Sexual Dimorphism in Neurodegeneration

There exist sex differences in neurodevelopmental and neurodegenerative disorders. For instance, multiple sclerosis is more common in women, whereas Parkinson’s disease is more common in men. Here is the latest research on sexual dimorphism in neurodegeneration

HLA Genetic Variation

HLA genetic variation has been found to confer risk for a wide variety of diseases. Identifying these associations and understanding their molecular mechanisms is ongoing and holds promise for the development of therapeutics. Find the latest research on HLA genetic variation here.

Super-resolution Microscopy

Super-resolution microscopy is the term commonly given to fluorescence microscopy techniques with resolutions that are not limited by the diffraction of light. Here are the latest discoveries pertaining to super-resolution microscopy.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.

Brain Lower Grade Glioma

Low grade gliomas in the brain form from oligodendrocytes and astrocytes and are the slowest-growing glioma in adults. Discover the latest research on these brain tumors here.

CD4/CD8 Signaling

Cluster of differentiation 4 and 8 (CD8 and CD8) are glycoproteins founds on the surface of immune cells. Here is the latest research on their role in cell signaling pathways.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.